Status:
COMPLETED
Pilot Study to Investigate the Efficacy of a Toothpaste in Providing Relief From Dentinal Hypersensitivity
Lead Sponsor:
GlaxoSmithKline
Conditions:
Dentinal Sensitivity
Hypersensitivity
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
A pilot study to determine the ability of a stannous fluoride containing toothpaste to provide immediate and short term relief from dentine Hypersensitivity compared to a control toothpaste.
Eligibility Criteria
Inclusion
- Inclusion:
- Self-reported history of dentinal hypersensitivity lasting more than 6 months and less than 10 years
- Teeth showing signs of facial/cervical gingival recession and/or signs of erosion or abrasion.
- Teeth having a gingival index score of less than or equal to 1
- Teeth with a clinical mobility less than or equal to 1
- sensitive teeth from those meeting the EAR, GI and mobility criteria at screening, with sensitivity as measured by tactile stimulus (Yeaple probe, tactile threshold 10g) and evaporative (air) stimulus (Schiff Sensitivity Score ≥ 2).
- Exclusion:
- Presence of chronic debilitating disease which could affect study outcomes.
- Any condition which causes xerostomia.
- Dental prophylaxis within 4 weeks of screening.
- Tongue or lip piercing or presence of dental implants.
- Professional desensitising treatment within 12 weeks of screening.
- Gross periodontal disease, treatment of periodontal disease (including surgery) within 12 months of screening, scaling or root planning within 3 months of screening.
- Teeth bleaching within 12 weeks of screening.
- Tooth with evidence of current or recent caries, or reported treatment of decay in 12 months of screening.
- Tooth with exposed dentine but with deep, defective or facial restorations, teeth used as abutments for fixed or removable partial dentures, teeth with full crowns or veneers, orthodontic bands or cracked enamel. Sensitive teeth with contributing aetiologies other than erosion, abrasion or recession of exposed dentine, or not expected to respond to treatment with an over-the counter dentifrice.
- Daily doses of a medication which could interfere with the perception of pain.
- Currently taking antibiotics or have taken antibiotics within 2 weeks of baseline.
- Individuals who require antibiotic prophylaxis for dental procedures.
Exclusion
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
118 Patients enrolled
Trial Details
Trial ID
NCT01494649
Start Date
September 1 2011
End Date
September 1 2011
Last Update
May 8 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
BioSci Research America, Inc.
Las Vegas, Nevada, United States, 89121